Reem Karmali - Publications, H-index & Citations

Reem Karmali

northwestern university

32H指数

359论文数

4.2K被引数

收录论文 66

发表时间

Long-term survival and cause-specific mortality after event-free survival at 24 months (EFS24) in mantle cell lymphoma: an international multicohort study 套细胞淋巴瘤在24个月无事件生存期（EFS24）后的长期生存和特定病因死亡率：一项国际多队列研究

Blood Cancer Journal

IF11.6

2026-09-22

OAAI

Yucai Wang; Melissa C. Larson; Umar Farooq; Sara Ekberg; Karin E. Smedby; Mikkel R. Simonsen; Peter de Nully Brown; Carsten U. Niemann; Eric J. Zhao; Alina S. Gerrie; Jeffrey M. Switchenko; David A. Bond; Veronika Bachanova; Stefan K. Barta; Brian T. Hill; Peter Martin; Alexey V. Danilov; Natalie S. Grover; Reem Karmali; Nilanjan Ghosh; Timothy S. Fenske; Brad S. Kahl; Alexandra Albertsson-Lindblad; Ingrid Glimelius; Ahmed Ludvigsen Al-Mashhadi; Thomas S. Larsen; Kami J. Maddocks; Eric Mou; Jonas Paludo; Grzegorz S. Nowakowski; Thomas M. Habermann; Matthew J. Maurer; Diego Villa; Jonathon B. Cohen; Tarec C. El-Galaly; Mats Jerkeman; James R. Cerhan

Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma 免疫疗法单独或联合化疗作为边缘区淋巴瘤一线治疗的比较有效性

Haematologica

IF7.9

2026-05-01

OAAI

Olszewski, Adam J.; Ollila, Thomas A.; Chihara, Dai; Shouse, Geoffrey; Grover, Natalie; Karmali, Reem; Torka, Pallawi; Thomas, Colin; Geethakumari, Praveen Ramakrishnan; Barta, Stefan K.; Bartlett, Nancy L.; Epperla, Narendranath

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton’s tyrosine kinase inhibitor therapy 套细胞淋巴瘤在序贯一线 bendamustine-rituximab 和二线 Bruton 酪氨酸激酶抑制剂治疗后的预后

Blood Cancer Journal

IF11.6

2026-04-25

OAAI

Yucai Wang; Melissa C. Larson; Steven R. Hwang; Diego Villa; Laveniya Kugathasan; Anita Kumar; Ashlee Joseph; Taylor R. Brooks; Brian T. Hill; David A. Bond; Kami J. Maddocks; Alexey Danilov; Christine Argao; Jia Ruan; Imran A. Nizamuddin; Brad S. Kahl; Natalie S. Grover; Nazneen B. Khan; Georgios N. Pongas; Izidore S. Lossos; Evguenia Ouchveridze; Aung M. Tun; Firas Baidoun; Muhamad Alhaj Moustafa; Zoey I. Harris; Javier L. Munoz; Philip R. Young; Craig A. Portell; Patrick M. Reagan; Christine E. Ryan; Reid W. Merryman; Arash Velayati; I. Brian Greenwell; Drew G. Gerber; Preetesh Jain; Michael L. Wang; Sabarish R. Ayyappan; Eric Mou; Lauren G. Banaszak; Priyanka A. Pophali; Anthony C. Stack; Marcus R. Messmer; Mayur S. Narkhede; Amitkumar Mehta; Tamara K. Moyo; Nilanjan Ghosh; Rahul S. Bhansali; Stefan K. Barta; Manali K. Kamdar; Jacob Anna; Alexander V. Stanisic; Reem Karmali; Matthew J. Maurer; James R. Cerhan; Jonathon B. Cohen; Peter Martin

Outcomes of Bispecific Antibodies After CAR T-Cell Failure for Large B-cell Lymphoma- Results from the ABC Consortium 大B细胞淋巴瘤在CAR T细胞治疗失败后使用双特异性抗体的疗效——ABC Consortium研究的结果

Blood Advances

IF7.1

2025-10-24

OAAI

Megan Melody; Natalie Grover; Stephanie Franco; Jason Romancik; Matthew Cortese; Tamara K. Moyo; Rahul S. Bhansali; Thomas Ollila; Vaishalee Kenkre; Lindsey Fitzgerald; Brian Hess; Matt Matasar; Geoffrey Shouse; Kaitlin Annunzio; Megan M. Herr; James A. Davis; Christy Jesme; Ari Pelcovits; Jonathan Moreira; Shuo Ma; Jane N. Winter; Adam Lin; Alexey Danilov; Ishan Roy; Stefan K. Barta; Leo I Gordon; Deborah Stephens; Jonathon B. Cohen; Narendranath Epperla; Reem Karmali

Exploring new treatment strategies for hard-to-treat double-hit and double-expressor lymphomas 探索难治性双-hit和双-表达淋巴瘤的新治疗策略

Immunotherapy

IF2.9

2025-10-13

OAAI

Max F. Kelsten; Reem Karmali

Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis CAR T细胞疗法后套细胞淋巴瘤疾病进展的治疗与结局：一项多中心分析

Blood Advances

IF7.1

2025-08-07

OAAI

Zachary D. Epstein-Peterson; Anath C. Lionel; Ashlee Joseph; Esther Drill; Suheil Albert Atallah-Yunes; Taylor R. Brooks; Elise A. Chong; Emeline R. Chong; Jamie Dela Cruz; Matthew J. Frank; Andrew Ip; Madiha Iqbal; Caron A. Jacobson; Manali K. Kamdar; Reem Karmali; Ofrat Beyar-Katz; Kami J. Maddocks; Matthew J. Matasar; Daniel McLoughlin; Reid W. Merryman

A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL 一项关于来那度胺和剂量调整EPOCH-R在MYC相关DLBCL中的多中心Ⅰ/Ⅱ期临床试验

Blood Advances

IF7.1

2025-07-29

OAAI

Kirk Cahill; James Godfrey; Chadi Nabhan; Justin Kline; Peter A. Riedell; Kenneth S. Cohen; Sunil Narula; Theodore G. Karrison; Jessica Robertson; Reem Karmali; Parameswaran Venugopal; Seo-Hyun Kim; Aaron P. Rapoport; Seung Tae Lee; Jennie Law; Paul A. S. Fishkin; Iris Isufi; Mario Velasco; Lynne Kaminer; Sonali M. Smith

Nivolumab in Combination with R-CHOP for Treatment-Naïve Diffuse Large B-Cell Lymphoma: An Evaluation of Safety and Efficacy 纳武利尤单抗联合R-CHOP方案治疗初治弥漫性大B细胞淋巴瘤：安全性与有效性的评估

Blood Advances

IF7.1

2025-07-28

OAAI

Oluwatobi Odetola; Shuo Ma; Jane Winter; Barbara Pro; Ishan Roy; Ping Xie; Bin Zhang; Qing Chen; George P. Koulogeorgas; Xinlei Mi; Ruohui Chen; Yangruijue Ma; Xiaodan Tang; Robert Bayer; Robert Eisner; Valerie Nelson; Habib Shaikh; Dean Tsarwhas; Faisal Saghir; Parameswaran Venugopal; Leo I. Gordon; Reem Karmali

Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study CAR T细胞疗法中结外受累对复发或难治性大B细胞淋巴瘤患者预后的影响——一项多中心队列研究的结果

Blood Cancer Journal

IF11.6

2025-06-21

OAAI

Frederique St-Pierre; Subodh Bhatta; Peter G. Doukas; Madeline Jenkin; Kaitlin Annunzio; Alexandra E. Rojek; Alyssa Gibson; Yun Kyoung Tiger; Brittany McCall; Khaled Alhamad; Alec Hansen; Juan P. Alderuccio; Olutobi Adewale; Keem Patel; Asaad Trabolsi; Izidore S. Lossos; Lindsey Fitzgerald; Thomas A. Ollila; Matthew J. Matasar; Justin Kline; Reem Karmali; Narendranath Epperla

Evaluation of Outcomes and Toxicities of Commercial Axicabtagene Ciloleucel (axi-cel) and Tisagenlecleucel (tisa-cel) for Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Real-World Evidence (RWE) from 10 US Academic Centers 评估商业用Axicabtagene Ciloleucel（axi-cel）和Tisagenlecleucel（tisa-cel）治疗复发或难治性（R/R）滤泡性淋巴瘤（FL）的结局和毒性的研究：来自10家美国学术中心的真实世界证据（RWE）

BLOOD

IF23.1

2024-11-05

PREAI

Sharp, John; Strati, Paolo; Bhatta, Subodh; Huang, Jennifer J.; Thomas, Colin; Reef, Daniel K.; Gorzewski, Alexander; Reinert, Catherine; Teferra, Andinet; Pelcovits, Ari; Ollila, Thomas; Maakaron, Joseph E.; Kamdar, Manali K.; Fitzgerald, Lindsey; Karmali, Reem; Grover, Natalie; Barta, Stefan K.; Voorhees, Timothy; Shadman, Mazyar; Ahmed, Sairah; Epperla, Narendranath

Final Response and Survival Results from a Phase II Trial of Pembrolizumab and Entinostat in Relapsed/Refractory Hodgkin Lymphoma Pembrolizumab和Entinostat治疗复发/难治性霍奇金淋巴瘤的II期试验最终应答和生存结果

BLOOD

IF23.1

2024-11-05

PREAI

Stuver, Robert; Vardhana, Santosha A.; Ganesan, Nivetha; Boardman, Alexander P.; Caron, Philip; Chang, Tiffany; David, Kevin A.; Epstein-Peterson, Zachary D.; Falchi, Lorenzo; Ghione, Paola; Hamlin, Paul A.; Hernandez-Ilizaliturri, Francisco; Horwitz, Steven; Intlekofer, Andrew M.; Johnson, William T.; Karmali, Reem; Lue, Jennifer Kimberly; Kumar, Anita; Luttwak, Efrat; Mahajan, Neena; Marouf, Amira; Noy, Ariela; Owens, Colette; Palomba, Maria Lia; Salles, Gilles; Schoder, Heiko; Sermer, David; Seshan, Venkatraman; Steiner, Raphael E.; Torka, Pallawi; Zelenetz, Andrew D.; von Keudell, Gottfried; Moskowitz, Alison

Treatment Patterns and Outcomes Following Progression of Disease Post-CAR-T Therapy in Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter Analysis CAR-T疗法后疾病进展的复发或难治性套细胞淋巴瘤患者的治疗方案与结局：一项多中心分析

BLOOD

IF23.1

2024-11-05

PREAI

Epstein-Peterson, Zachary D.; Lionel, Anath C.; Joseph, Ashlee; Drill, Esther; Atallah-Yunes, Suheil Albert; Brooks, Taylor R.; Chong, Elise A.; Chong, Emeline R.; Dela Cruz, Jamie; Frank, Matthew J.; Ip, Andrew; Iqbal, Madiha; Jacobson, Caron A.; Kamdar, Manali K.; Karmali, Reem; Maddocks, Kami J.; Matasar, Matthew; Merryman, Reid W.; Munoz, Javier; Riedell, Peter A.; Ryan, Christine E.; Salles, Gilles; Sauter, Craig S.; Sawalha, Yazeed; Shouval, Roni; Shukla, Navika; Stanisic, Alexander, V; Therwhanger, Dylan; Van Besien, Herman; Wang, Yucai; Yamshon, Samuel; Zelenetz, Andrew D.; Palomba, Maria Lia; Jain, Preetesh; Kumar, Anita

Clinical Outcomes of Transformed Follicular Lymphoma with CAR T-Cell Therapy: A US Multicenter Real-World Analysis CAR T细胞疗法治疗转化型滤泡性淋巴瘤的临床结局：一项美国多中心真实世界分析

BLOOD

IF23.1

2024-11-05

PREAI

Cortese, Matthew J.; Herr, Megan M.; Nair, Nisha; Romancik, Jason; Grover, Natalie; Bhansali, Rahul S.; Thomas, Colin; Moyo, Tamara K.; Kenkre, Vaishalee P.; Ollila, Thomas; Hess, Brian; Fitzgerald, Lindsey; Shouse, Geoffrey; Matasar, Matthew; Annunzio, Kaitlin; Davis, James A.; Jesme, Christy; Pelcovits, Ari; Melody, Megan; Moreira, Jonathan; Lin, Adam Yuh; Ma, Shuo; Winter, Jane N.; Niu, Alex; V. Danilov, Alexey; Shah, Nirav N.; Stephens, Deborah M.; Cohen, Jonathon B.; Gordon, Leo I.; Barta, Stefan K.; Epperla, Narendranath; Karmali, Reem

Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Transcend FL 2-Year Follow-up 利索卡巴肽马瑞克塞尔（liso-cel）在复发或难治性（R/R）滤泡性淋巴瘤（FL）患者（pts）中的2年随访：超越FL研究

BLOOD

IF23.1

2024-11-05

PREAI

Nastoupil, Loretta; Dahiya, Saurabh; Palomba, Maria Lia; Garcia-Sancho, Alejandro Martin; Reguera, Juan Luis; Kuruvilla, John; Jaeger, Ulrich; Cartron, Guillaume; Izutsu, Koji; Dreyling, Martin; Kahl, Brad S.; Ghesquieres, Herve; Ardeshna, Kirit; Goto, Hideki; Barbui, Anna Maria; Abramson, Jeremy S.; Borchmann, Peter; Fleury, Isabelle; Mielke, Stephan; Skarbnik, Alan P.; Kamdar, Manali; Karmali, Reem; Viardot, Andreas; Farazi, Thalia; Kao, Grace Shih Hui; Vedal, Min; Nishii, Rina; Papuga, Jessica; Kumar, Jinender; Morschhauser, Franck

MANTLE CELL, FOLLICULAR, WALDENSTROM'S, AND OTHER INDOLENT B CELL LYMPHOMAS: CLINICAL AND EPIDEMIOLOGICAL 套细胞、滤泡性、Waldenström's及其他惰性B细胞淋巴瘤：临床与流行病学

BLOOD

IF23.1

2024-11-05

PREAI

Wang, Jie; Zhou, Jihao; Wang, Yucai; Munoz, Javier L.; Shim, Kevin G.; Moustafa, Muhamad Alhaj; Baidoun, Firas; Annunzio, Kaitlin; Epperla, Narendranath; Mclane, Michael; Karimi, Yasmin H.; Luu, Binh; Spurgeon, Stephen E.; Chang, Cheryl; Wan, Zihan; Gathers, Diamone; King, Emily R.; Watkins, Marcus P.; Bartlett, Nancy L.; Ryan, Christine E.; Gerhard, Genevieve M.; Armand, Philippe; Lacasce, Ann S.; Vaddaraju, Vedha; Wallace, Danielle S.; Kenkre, Vaishalee P.; Junge, Chase; Grover, Natalie; Florindez, Jorge A.; Karmali, Reem; V. Stanisic, Alexander; Zhang, Chen; Venugopal, Parameswaran; Ying, Grace; Gribbin, Caitlin; Ruan, Jia; Shukla, Navika; Smith, Sonali M.; Zelikson, Viktoriya; Williams, Michael E.; Barta, Stefan K.; Elghawy, Omar; Schade, Jake; Navalekar, Rohini; Matasar, Matthew; Evens, Andrew M.; V. Danilov, Alexey; Fenske, Timothy S.

Evaluation of prognostic factors in patients with high-risk classical Hodgkin lymphoma undergoing autologous transplantation

BLOOD ADVANCES

IF7.1

2024-10-23

OAAI

Epperla, Narendranath; Huang, Ying; Cashen, Amanda F.; Vaughn, John L.; Hanel, Walter; Badar, Talha; Barta, Stefan K.; Caimi, Paolo F.; Sethi, Tarsheen K.; Reddy, Nishitha; Karmali, Reem; Bello, Celeste; Chavez, Julio C.; Kothari, Shalin K.; Hernandez-Ilizaliturri, Francisco J.; Svoboda, Jakub; Lansigan, Frederick; Glenn, Martha J.; Cohen, Jonathon B.; Sorge, Caryn; Christian, Beth; Herrera, Alex F.; Hamadani, Mehdi; Costa, Luciano J.; Xavier, Ana C.

Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study

BLOOD CANCER JOURNAL

IF11.6

2024-10-18

OAAI

Grover, Natalie S.; Annunzio, Kaitlin; Watkins, Marcus; Torka, Pallawi; Karmali, Reem; Anampa-Guzman, Andrea; Oh, Timothy S.; Reves, Heather; Tavakkoli, Montreh; Hansinger, Emily; Christian, Beth; Thomas, Colin; Barta, Stefan K.; Geethakumari, Praveen Ramakrishnan; Bartlett, Nancy L.; Shouse, Geoffrey; Olszewski, Adam J.; Epperla, Narendranath

High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series

BLOOD ADVANCES

IF7.1

2024-10-11

PREAI

Epperla, Narendranath; Zayac, Adam S.; Landsburg, Daniel J.; Bock, Allison M.; Nowakowski, Grzegorz S.; Ayers, Emily C.; Girton, Mark; Hu, Marie; Beckman, Amy; Li, Shaoying; Medeiros, L. Jeffrey; Chang, Julie E.; Kurt, Habibe; Sandoval-Sus, Jose; Ansari-Lari, Mohammad Ali; Kothari, Shalin K.; Kress, Anna; Xu, Mina L.; Torka, Pallawi; Sundaram, Suchitra; Smith, Stephen D.; Naresh, Kikkeri N.; Karimi, Yasmin; Bond, David A.; Evens, Andrew M.; Naik, Seema G.; Kamdar, Manali; Haverkos, Bradley M.; Karmali, Reem; Farooq, Umar; Vose, Julie M.; Rubinstein, Paul; Chaudhry, Amina; Olszewski, Adam J.

Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study (JUL, 10.1038/s41591-024-02986-9, 2024)

NATURE MEDICINE

IF50

2024-07-09

OAAI

Morschhauser, Franck; Dahiya, Saurabh; Palomba, M. Lia; Garcia-Sancho, Alejandro Martin; Ortega, Juan Luis Reguera; Kuruvilla, John; Jaeger, Ulrich; Cartron, Guillaume; Izutsu, Koji; Dreyling, Martin; Kahl, Brad; Ghesquieres, Herve; Ardeshna, Kirit; Goto, Hideki; Barbui, Anna Maria; Abramson, Jeremy S.; Borchmann, Peter; Fleury, Isabelle; Mielke, Stephan; Skarbnik, Alan; de Vos, Sven; Kamdar, Manali; Karmali, Reem; Viardot, Andreas; Farazi, Thalia; Fasan, Omotayo; Lymp, James; Vedal, Min; Nishii, Rina; Avilion, Ariel; Papuga, Jessica; Kumar, Jinender; Nastoupil, Loretta J.

Anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed or refractory large B-cell lymphoma: A multicenter study

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2024-06-04

PREAI

Tun, Aung M.; Patel, Romil D.; St-Pierre, Frederique; Ouchveridze, Evguenia; Niu, Alex; Thordardottir, Thorunn; Obasi, Jennifer; Rosenthal, Allison; Pophali, Priyanka A.; Fenske, Timothy S.; Karmali, Reem; Ahmed, Sairah; Johnston, Patrick B.

研究方向